Tamper-Resistant Prescription Pads
On June 26, 2008, the National Council for Prescription Drug Programs (NCPDP) held a second industry forum in an effort to review the implementation of the first phase of the CMS tamper-resistant regulations and to discuss next steps necessary to ensure a smooth transition into the second phase of implementation on October 1. As a result of this meeting, industry standards for copy, erasure/modification, and counterfeit resistance have been clarified. Also, CMS had previously stated that prescriptions printed from EMRs or ePrescribing applications would likely need special copy resistant paper to be in compliance as of October 1, 2008. CMS is now clarifying that guidance, based on its awareness of improved printing capabilities, and is now stating that while special paper may be used to achieve copy resistance, it is not a requirement. EMR or ePrescribing generated prescriptions may be printed on plain paper and be fully compliant with all three categories of the tamper-resistant regulations provided they contain at least one feature from each of the three categories.
The attached letter recommends best practices developed by the industry forum and is strongly suggested for adoption in order to meet the tamper-resistant requirements.
In addition to this guidance, we have created a template letter for you to use when communicating this information to your prescriber community. You are encouraged to modify this letter with your state specific requirements.